Glucocorticoid Therapy in Sepsis/Shock Caused by Gram-Negative Microorganisms†
- 1 November 1975
- journal article
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 23 (11) , 493-502
- https://doi.org/10.1111/j.1532-5415.1975.tb00895.x
Abstract
A review of the literature reveals that glucocorticoids have: 1) a protective effect both in vitro and in vivo against bacterial endotoxins and exotoxins, and 2) a protective or therapeutic effect in sepsis/shock caused by Gram-negative microorganisms. At the Columbia Presbyterian Medical Center, the 1968-1973 mortality rate for general sepsis/shock due to Gram-negative organisms was 16.6 percent and for urologic sepsis/shock 15.3 percent. This low rate was the result of early diagnosis and early use of massive dosages of glucocorticoids (hydrocortisone, methylprednisolone, dexamethasone), beta-adrenergic isoproterenol, and bactericidal antibiotics (gentamicin, kanamycin, carbenicillin, cephalothin-cefazolin, ampicillin).Keywords
This publication has 34 references indexed in Scilit:
- Clinical Trial Design in Studies of Corticosteroids for Bacterial InfectionsAnnals of Internal Medicine, 1974
- Effect of Endotoxin on Induced Liver EnzymesThe Journal of Infectious Diseases, 1973
- Circulatory deterioration as the determinant of energy metabolism in endotoxin shockJournal of Surgical Research, 1972
- Treatment of gram-negative shockThe American Journal of Medicine, 1971
- MECHANISMS OF ENDOTOXIN SHOCK IN RATS AND THE ANTI-ENDOTOXIC EFFECT OF GLUCOCORTICOIDS AND ENDOTOXIN-CONDITIONINGThe Japanese Journal of Physiology, 1969
- The impairment of glucogenesis by gram negative infectionMetabolism, 1968
- Gram-negative rod bacteremiaThe American Journal of Medicine, 1965
- EFFECTS OF BACTERIAL ENDOTOXIN ON METABOLISMThe Journal of Experimental Medicine, 1959
- The Shock Syndrome Associated with Bacteremia Due to Gram-Negative BacilliArchives of internal medicine (1960), 1958
- The in Vitro Production of Cortisone by Mammalian CellsScience, 1950